课题基金 / 基金详情

Mechanisms of Retinal Vascular Permeability in Diabetes

Mechanisms of Retinal Vascular Permeability in Diabetes
糖尿病视网膜血管通透性的机制
批准号:
10701684
负责人:
David Antonetti
金额:
$45.16万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
未结题
起止时间:
1998-09-01 至 2025-07-31

项目摘要

项目成果

David Antonetti的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Diabetes mellitus remains a leading cause of blindness world-wide and epidemiological data from the World Health Organization reveal over 422 million adults live with diabetes and the rate of disease onset continues to rise. According to the National Eye Institute 10.2 million US adults 40 years and older have diabetes mellitus, and 8.2% with vision threatening retinopathy. Macular edema remains closely linked to loss of vision and current therapies focus on mechanisms to prevent cytokine driven changes in vascular permeability that promote edema. Our previous research has fundamentally contributed to understanding the molecular mechanisms that lead to vascular endothelial growth factor (VEGF) induced retinal vessel permeability. The development of effective anti-VEGF therapies has been a welcome addition for the treatment of diabetic retinopathy, but this approach remains insufficient and new therapies are needed. In the current application we now focus on understanding the process of blood-retinal barrier regeneration. Research has identified a required role for norrin in formation of the blood-retinal barrier. Here, we explore the exciting potential for norrin to restore vascular barrier properties after VEGF-induced injury. The studies promise to shed new light on how these two critical cytokines interact to control retinal vessel barrier properties. Further, preliminary data reveal completely novel interactions of the norrin signaling molecule, disheveled (DVL), binding directly to tight junction proteins. The role of these protein interactions on norrin signaling and tight junction biology will be elucidated at a molecular level in order to understand the mechanisms of norrin action on barrier restoration. We expect this proposal will provide novel information on regulation of the blood-retinal barrier in health and in diabetes and will provide a framework from which to develop potential new therapeutic options to treat macular edema.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
Isolation and characterization of retinal endothelial cells.
视网膜内皮细胞的分离和表征。
DOI: 10.1385/1-59259-419-0:365
发表时间: 2003
期刊: Methods in molecular medicine.
影响因子: --
作者: [Antonetti,DavidA, Wolpert,EllenB]
通讯作者: Wolpert,EllenB
DOI: 10.1021/pr7007913
发表时间: 2009-02
期刊: JOURNAL OF PROTEOME RESEARCH
影响因子: 4.4
作者: [Sundstrom, Jeffrey M., Tash, Brian R., Murakami, Tomoaki, Flanagan, John M., Bewley, Maria C., Stanley, Bruce A., Gonsar, Kristin B., Antonetti, David A.]
通讯作者: Antonetti, David A.
DOI: 10.1371/journal.pone.0018076
发表时间: 2011-03-25
期刊: PloS one
影响因子: 3.7
作者: [Cai J, Wu L, Qi X, Shaw L, Li Calzi S, Caballero S, Jiang WG, Vinores SA, Antonetti D, Ahmed A, Grant MB, Boulton ME]
通讯作者: Boulton ME
DOI: 10.1042/bj20111961
发表时间: 2012-09-15
期刊: The Biochemical journal
影响因子: --
作者: [Titchenell PM, Lin CM, Keil JM, Sundstrom JM, Smith CD, Antonetti DA]
通讯作者: Antonetti DA
17
    The role of heme in retinal vascular development and disease
    Leica SP8 Confocal Microscope
    Discovering novel atypical PKC inhibitors as in vivo chemical probes - Supplement to Promote Diversity
    Induction of the blood-retinal barrier
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: